Curated News
By: NewsRamp Editorial Staff
November 06, 2026
SS Innovations' SSi Mantra Hits 15K Procedures, Eyes Global Expansion
TLDR
- SS Innovations' SSi Mantra has enabled over 15,000 procedures and 66% revenue growth, positioning the company to challenge established surgical robotics players globally.
- The SSi Mantra platform integrates 4K 3D visualization, surgeon-controlled imaging, and a modular design with up to five robotic arms to support diverse surgical procedures.
- Telesurgery via SSi Mantra extends specialist surgical care to underserved communities, with over 200 telesurgeries performed including 27 cardiac cases.
- SS Innovations has performed approximately 750 cardiac procedures using its SSi Mantra system, showcasing the platform's versatility beyond general surgery.
Impact - Why it Matters
The rapid adoption of SS Innovations' SSi Mantra robotic surgical system, with over 15,000 procedures performed and strong revenue growth, signals a significant shift in the surgical robotics market. The platform's affordability and advanced features, such as 4K 3D visualization and modular design, could democratize access to minimally invasive surgery, especially in underserved regions through telesurgery. As SS Innovations expands manufacturing and pursues regulatory approvals in Europe and the US, it may intensify competition and drive down costs, ultimately benefiting patients and healthcare providers worldwide. The company's success also highlights the growing role of emerging market innovators in high-tech medical devices.
Summary
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is gaining significant commercial traction with its SSi Mantra surgical robotic platform. In a recent interview with The Motley Fool’s Rachel Warren, CEO Dr. Sudhir Srivastava revealed that the company has performed more than 15,000 procedures using its robotic systems, including approximately 750 cardiac surgeries. He also highlighted that over 200 telesurgeries have been completed, including 27 cardiac procedures, as the company seeks to extend specialist surgical expertise to underserved communities. Srivastava emphasized the SSi Mantra’s differentiated engineering, including 4K 3D visualization, surgeon-controlled anatomical imaging, and a modular design supporting up to five robotic arms.
SS Innovations is preparing to expand its Indian manufacturing capacity through a planned 10-acre facility, with the objective of bringing additional production capabilities in-house. Regulatory applications in Europe and the United States are also progressing, with management targeting international expansion through direct sales and opportunities in ambulatory surgery centers. The company is experiencing strong commercial momentum, with first-half 2026 revenue increasing approximately 66% year-over-year to about $25 million. For more details, Read More>>. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII. MissionIR is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations' SSi Mantra Hits 15K Procedures, Eyes Global Expansion
